D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
Snowflake
SNOW
|
+$429M |
| 3 |
Citigroup
C
|
+$383M |
| 4 |
Oracle
ORCL
|
+$365M |
| 5 |
Sea Limited
SE
|
+$360M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$597M |
| 2 |
Apple
AAPL
|
+$579M |
| 3 |
Mastercard
MA
|
+$525M |
| 4 |
Walt Disney
DIS
|
+$428M |
| 5 |
Booking.com
BKNG
|
+$416M |
Sector Composition
| 1 | Technology | 19.98% |
| 2 | Consumer Discretionary | 13.5% |
| 3 | Financials | 10.53% |
| 4 | Healthcare | 10.18% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNR
2751
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $745K | ﹤0.01% |
35,471
+1,804
| +5% | +$37.9K |
|
|
SANBU
2752
DELISTED
Sanaby Health Acquisition Corp. I Unit
SANBU
| $743K | ﹤0.01% |
+73,302
| New | +$743K |
|
2753
ResMed
RMD
$39.6B
| $742K | ﹤0.01% |
+2,849
| New | +$742K |
|
2754
Live Nation Entertainment
LYV
$40.3B
| $737K | ﹤0.01% |
6,161
-3,367
| -35% | -$403K |
|
2755
PLDT
PHI
$4.22B
| $734K | ﹤0.01% |
20,535
+1,516
| +8% | +$54.2K |
|
|
DSL
2756
DoubleLine Income Solutions Fund
DSL
$1.44B
| $725K | ﹤0.01% |
45,000
| – | – |
|
2757
McCormick & Company Non-Voting
MKC
$18.5B
| $725K | ﹤0.01% |
7,500
-33,308
| -82% | -$3.22M |
|
2758
CuriosityStream
CURI
$281M
| $721K | ﹤0.01% |
+121,525
| New | +$721K |
|
2759
Liberty Latin America Class A
LILA
$1.5B
| $721K | ﹤0.01% |
+61,832
| New | +$721K |
|
2760
Employers Holdings
EIG
$983M
| $720K | ﹤0.01% |
17,401
-7,621
| -30% | -$315K |
|
2761
Financial Institutions
FISI
$545M
| $720K | ﹤0.01% |
22,629
-959
| -4% | -$30.5K |
|
2762
Acadia Healthcare
ACHC
$2.01B
| $719K | ﹤0.01% |
+11,841
| New | +$719K |
|
2763
Sonder
SOND
$22.9M
| $719K | ﹤0.01% |
3,608
| – | – |
|
|
FAZE
2764
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $716K | ﹤0.01% |
70,794
-60,893
| -46% | -$616K |
|
2765
Lennar Class B
LEN.B
$34B
| $715K | ﹤0.01% |
7,866
-7,624
| -49% | -$693K |
|
2766
LGI Homes
LGIH
$1.39B
| $714K | ﹤0.01% |
+4,625
| New | +$714K |
|
2767
AXIS Capital
AXS
$7.75B
| $711K | ﹤0.01% |
13,047
+7,421
| +132% | +$404K |
|
2768
Stoneridge
SRI
$228M
| $711K | ﹤0.01% |
36,030
+9,034
| +33% | +$178K |
|
|
IMDX
2769
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$88.1M
| $710K | ﹤0.01% |
16,355
+6,124
| +60% | +$266K |
|
2770
AB InBev
BUD
$114B
| $709K | ﹤0.01% |
+11,709
| New | +$709K |
|
|
HCICW
2771
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
| $709K | ﹤0.01% |
853,875
| – | – |
|
2772
Organogenesis Holdings
ORGO
$625M
| $707K | ﹤0.01% |
76,505
-56,812
| -43% | -$525K |
|
2773
Cosan
CSAN
$2.57B
| $704K | ﹤0.01% |
44,880
-17,439
| -28% | -$274K |
|
2774
Sierra Bancorp
BSRR
$408M
| $702K | ﹤0.01% |
25,845
-3,870
| -13% | -$105K |
|
2775
Athira Pharma
ATHA
$14.2M
| $700K | ﹤0.01% |
+53,700
| New | +$700K |
|